Raman In-Depth Focus 2018
Posted: 18 December 2018 | European Pharmaceutical Review | No comments yet
This In-Depth Focus covers drop-coating deposition Raman (DCDR) spectroscopy for metabolite profiling and recent developments of Raman spectroscopy for the qualitative analysis of falsified and substandard medicines.
Testing for falsified and substandard medicines can often be lengthy and require high‑level equipment and staff. There is, therefore, an increasing need for fast, reliable and, if possible, portable solutions to detect these products. Laureen Coic and colleagues from the University of Liege in Belgium investigate the use of Raman spectroscopy for the qualitative analysis of falsified and substandard medicines and discuss their findings.
The increased interest in metabolite profiling calls for improved analytical techniques with greater performance. Derya Cebeci from PortMera Corp., Anik Alam from Duquesne University, USA and Dor Ben-Amotz from Purdue University, USA, evaluate the application of drop-coating deposition Raman spectroscopy for use in metabolite profiling.
This In-Depth Focus is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Issue
Related topics
Related organisations
Related people
Derya Cebeci-Maltaş, Dor Ben-Amotz, Laureen Coic, Md Anik Alam
